Stage III Adrenal Cortex Carcinoma
3 clinical trials · Condition
◉ Watch Stage III Adrenal Cortex Carcinoma
| Record | Firm | Date |
|---|---|---|
| Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer (NCT06006013) | Emory University | 2025-01-15 |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer (NCT02720484) | Northwestern University | 2016-03-30 |
Track Stage III Adrenal Cortex Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.